Sfoglia per Autore
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
2019-10-01 Incorvaia L.; Fanale D.; Badalamenti G.; Barraco N.; Bono M.; Corsini L.R.; Galvano A.; Gristina V.; Listi A.; Vieni S.; Gori S.; Bazan V.; Russo A.
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
2020-01-01 Incorvaia L.; Fanale D.; Bono M.; Calo V.; Fiorino A.; Brando C.; Corsini L.R.; Cutaia S.; Cancelliere D.; Pivetti A.; Filorizzo C.; La Mantia M.; Barraco N.; Cusenza S.; Badalamenti G.; Russo A.; Bazan V.
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
2020-01-01 Fanale, Daniele; Incorvaia, Lorena; Filorizzo, Clarissa; Bono, Marco; Fiorino, Alessia; Calò, Valentina; Brando, Chiara; Corsini, Lidia Rita; Barraco, Nadia; Badalamenti, Giuseppe; Russo, Antonio; Bazan, Viviana
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis
2020-01-01 Galvano A.; Castiglia M.; Rizzo S.; Silvestris N.; Brunetti O.; Vaccaro G.; Gristina V.; Barraco N.; Bono M.; Guercio G.; Graceffa G.; Fulfaro F.; Gori S.; Bazan V.; Russo A.
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score
2020-01-01 Galvano A.; Peri M.; Guarini A.A.; Castiglia M.; Grassadonia A.; De Tursi M.; Irtelli L.; Rizzo S.; Bertani A.; Gristina V.; Barraco N.; Russo A.; Natoli C.; Bazan V.
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes
2020-01-01 Incorvaia L.; Fanale D.; Badalamenti G.; Bono M.; Calo V.; Cancelliere D.; Castiglia M.; Fiorino A.; Pivetti A.; Barraco N.; Cutaia S.; Russo A.; Bazan V.
TTF-1/p63-positive poorly differentiated NSCLC: A histogenetic hypothesis from the basal reserve cell of the terminal respiratory unit
2020-01-01 Cabibi D.; Bellavia S.; Giannone A.G.; Barraco N.; Cipolla C.; Martorana A.; Rodolico V.; Cajozzo M.; Florena A.M.
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
2021-01-01 Gristina, Valerio; La Mantia, Maria; Galvano, Antonio; Cutaia, Sofia; Barraco, Nadia; Castiglia, Marta; Perez, Alessandro; Bono, Marco; Iacono, Federica; Greco, Martina; Calcara, Katia; Calò, Valentina; Rizzo, Sergio; Incorvaia, Lorena; Lisanti, Maria Chiara; Santanelli, Giulia; Sardo, Delia; Inguglia, Sara; Insalaco, Lavinia; Castellana, Luisa; Cusenza, Stefania; Pantuso, Gianni; Russo, Antonio; Bazan, Viviana
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
2021-01-01 Gristina V.; Galvano A.; Castellana L.; Insalaco L.; Cusenza S.; Graceffa G.; Iacono F.; Barraco N.; Castiglia M.; Perez A.; Rizzo S.; Russo A.; Bazan V.
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups
2021-01-01 Francesco Passiglia, Antonio Galvano, Valerio Gristina, Nadia Barraco, Marta Castiglia, Alessandro Perez, Maria La Mantia, Antonio Russo, Viviana Bazan
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
2021-01-01 Incorvaia L.; Badalamenti G.; Fanale D.; Vincenzi B.; Luca I.D.; Algeri L.; Barraco N.; Brando C.; Bonasera A.; Bono M.; Castiglia M.; Cancelliere D.; Cani M.; Rita Corsini L.; Fiorino A.; Galvano A.; Pedone E.; Perez A.; Pivetti A.; Graceffa G.; Pantuso G.; Cabibi D.; Russo A.; Bazan V.
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials
2021-05-01 Galvano A.; Gristina V.; Malapelle U.; Pisapia P.; Pepe F.; Barraco N.; Castiglia M.; Perez A.; Rolfo C.; Troncone G.; Russo A.; Bazan V.
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
2021-08-01 Bono M.; Fanale D.; Incorvaia L.; Cancelliere D.; Fiorino A.; Calo V.; Dimino A.; Filorizzo C.; Corsini L.R.; Brando C.; Madonia G.; Cucinella A.; Scalia R.; Barraco N.; Guadagni F.; Pedone E.; Badalamenti G.; Russo A.; Bazan V.
Cancer of the Thyroid
2021-10-07 Gristina, Valerio; Barraco, Nadia; Buscemi, Silvio; Incorvaia, Lorena; Berruti, Alfredo
Future perspectives
2022-01-01 Incorvaia L.; La Mantia M.; Cutaia S.; Gristina V.; Galvano A.; Barraco N.; Perez A.; Badalamenti G.; Russo A.; Bazan V.
Current clinically validated applications of liquid biopsy
2022-01-01 Capoluongo E.; Rolfo C.; Galvano A.; Gristina V.; Perez A.; Barraco N.; La Mantia M.; Incorvaia L.; Badalamenti G.; Russo A.; Bazan V.
Molecular tumor board
2022-01-01 La Mantia M.; Busuito G.; Spinnato V.; Gristina V.; Galvano A.; Cutaia S.; Barraco N.; Perez A.; Cusenza S.; Incorvaia L.; Badalamenti G.; Russo A.; Bazan V.
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
2022-01-13 Fanale D.; Corsini L.R.; Scalia R.; Brando C.; Cucinella A.; Madonia G.; Dimino A.; Filorizzo C.; Barraco N.; Bono M.; Fiorino A.; Magrin L.; Sciacchitano R.; Perez A.; Russo T.D.B.; Pantuso G.; Russo A.; Bazan V.
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
2022-05-01 Fanale D.; Pivetti A.; Cancelliere D.; Spera A.; Bono M.; Fiorino A.; Pedone E.; Barraco N.; Brando C.; Perez A.; Guarneri M.F.; Russo T.D.B.; Vieni S.; Guarneri G.; Russo A.; Bazan V.
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code
2022-07-13 Cammarata, Giuseppe; Barraco, Nadia; Giusti, Ilaria; Gristina, Valerio; Dolo, Vincenza; Taverna, Simona
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile